Inventor
BEL AIBA RACHIDA SIHAM
DE16 patents
⚠️ This page may combine multiple inventors who share the name “BEL AIBA RACHIDA SIHAM”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
PIERIS PHARMACEUTICALS GMBH
15 patentsUS10526382B2Jan 7, 2020
Human neutrophil gelatinase-associated lipocalin (hNGAL) muteins capable of binding angiopoietin-2 (Ang-2) and methods of use thereof
PIERIS PHARMACEUTICALS GMBH6 citations82
US10273275B2Apr 30, 2019
Muteins of human lipocalin 2 with affinity for glypican-3 (GPC3) and methods of use thereof
PIERIS PHARMACEUTICALS GMBH10 citations82
US11261221B2Mar 1, 2022
Proteins specific for CD137
PIERIS PHARMACEUTICALS GMBH2 citations72
US10501510B2Dec 10, 2019
Muteins of human tear lipocalin capable of binding lymphocyte-activation gene 3 (LAG-3) and methods of use thereof
PIERIS PHARMACEUTICALS GMBH4 citations71
US12195503B2Jan 14, 2025
Proteins specific for CD137
PIERIS PHARMACEUTICALS GMBH0 citations62
US11034737B2Jun 15, 2021
Proteins specific for calcitonin gene-related peptide
PIERIS PHARMACEUTICALS GMBH1 citations61
US11034738B2Jun 15, 2021
Nucleic acid molecules encoding human neutrophil gelatinase-associated lipocalin (hNGAL) which bind angiopoietin-2 (Ang-2)
PIERIS PHARMACEUTICALS GMBH0 citations61
US10927156B2Feb 23, 2021
Human tear lipocalin muteins which specifically bind lymphocyte activation gene-3 (LAG3) and method of use thereof to stimulate an immune response
PIERIS PHARMACEUTICALS GMBH1 citations61
US11919931B2Mar 5, 2024
Anti-cancer fusion polypeptide capable of binding both CD137 and glypican-3 (GPC3)
PIERIS PHARMACEUTICALS GMBH1 citations60
US10913778B2Feb 9, 2021
Anti-cancer fusion polypeptides, encoding nucleic acids and methods of using polypeptides
PIERIS PHARMACEUTICALS GMBH1 citations60
US11773147B2Oct 3, 2023
Lipocalin muteins with binding affinity for LAG-3
PIERIS PHARMACEUTICALS GMBH1 citations59
US11168119B2Nov 9, 2021
Lipocalin muteins with binding affinity for LAG-3
PIERIS PHARMACEUTICALS GMBH1 citations59
US10865250B2Dec 15, 2020
Anti-cancer fusion polypeptide
PIERIS PHARMACEUTICALS GMBH1 citations58
US12486330B2Dec 2, 2025
Fusion proteins specific for CD137 and GPC3
PIERIS PHARMACEUTICALS GMBH0 citations53
US10787491B2Sep 29, 2020
Nucleic acid molecules encoding muteins of human lipocalin 2 with affinity for glypican-3 (GPC3)
PIERIS PHARMACEUTICALS GMBH0 citations50